Kimberly-Clark Buys Ballard--The Device Industry's No Man's Land
While Kimberly-Clark's acquisition of Ballard Medical Products doesn't have the seismic impact of Medtronic's acquisition of Arterial Vascular Engineering, it's still a big deal--nearly three-quarters of a billion dollars in size. More importantly, it represents the kind of deal-making that is relevant to most hospital supply and device companies.
You may also be interested in...
The Scientific Committee on Consumer Safety will consider available safety data for prostaglandin analogs isopropyl cloprostenate, ethyl tafluprostamide and others with known use in eyelash-growth cosmetic products in the EU. Currently, the substances are not restricted in cosmetic products.
Thermo Fisher Scientific has agreed to buy Mesa Biotech for $450m in cash and Hillrom will acquire Bardy Diagnostics for $375m in cash. Both deals will add complementary digital health solutions, which may be a continued trend in 2021.
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.